We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.05B
Cap. Flow %
8.49%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,118
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAPT
1126
DELISTED
RAPT Therapeutics
RAPT
$3.73M 0.02%
15,012
+5,319
+55% +$1.41M
ACHR.WS icon
1127
CALL
Archer Aviation Redeemable Warrants
ACHR.WS
$22.5M
$3.72M 0.02%
+419,101
New +$706K
PRAX icon
1128
Praxis Precision Medicines
PRAX
$8.8B
$3.72M 0.02%
13,421
+832
+7% +$226K
ALLY icon
1129
Ally Financial
ALLY
$13.3B
$3.72M 0.02%
+72,790
New +$3.77M
BKE icon
1130
Buckle
BKE
$2.25B
$3.71M 0.02%
93,790
-21,796
-19% -$930K
CME icon
1131
CME Group
CME
$92.3B
$3.71M 0.02%
+19,182
New +$3.89M
BITE
1132
DELISTED
Bite Acquisition Corp.
BITE
$3.7M 0.02%
+380,395
New +$3.68M
LGV.WS
1133
CALL
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$3.7M 0.02%
374,151
+95,091
+34% +$128K
CEQP
1134
DELISTED
Crestwood Equity Partners LP
CEQP
$3.7M 0.02%
130,312
+46,139
+55% +$1.28M
IPOF
1135
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$3.7M 0.02%
364,386
FE icon
1136
FirstEnergy
FE
$28.5B
$3.7M 0.02%
103,758
-31,155
-23% -$1.18M
DXJ icon
1137
WisdomTree Japan Hedged Equity Fund
DXJ
$7.23B
$3.68M 0.02%
58,270
+44,525
+324% +$2.74M
HCAT icon
1138
Health Catalyst
HCAT
$159M
$3.67M 0.02%
+73,321
New +$4M
MCHP icon
1139
Microchip Technology
MCHP
$42.3B
$3.65M 0.02%
47,626
-21,192
-31% -$1.59M
BFLY.WS
1140
CALL
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$3.65M 0.02%
350,000
ORC
1141
Orchid Island Capital
ORC
$1.3B
$3.64M 0.02%
149,029
-47,949
-24% -$1.21M
EVCM icon
1142
EverCommerce
EVCM
$2.09B
$3.64M 0.02%
+220,600
New +$4.06M
ATSG
1143
DELISTED
Air Transport Services Group
ATSG
$3.64M 0.02%
140,941
-76,850
-35% -$1.94M
MRSN
1144
DELISTED
Mersana Therapeutics
MRSN
$3.63M 0.02%
15,389
+14,595
+1,838% +$4.26M
STE icon
1145
Steris
STE
$21.3B
$3.62M 0.02%
17,738
+3,192
+22% +$683K
LNG icon
1146
Cheniere Energy
LNG
$53.6B
$3.62M 0.02%
37,088
+4,971
+15% +$435K
NDSN icon
1147
Nordson
NDSN
$16.6B
$3.6M 0.01%
15,117
+3,607
+31% +$833K
CALM icon
1148
Cal-Maine
CALM
$4.2B
$3.6M 0.01%
+99,459
New +$3.55M
SPKB
1149
DELISTED
Silver Spike Acquisition Corp II Class A Ordinary Shares
SPKB
$3.59M 0.01%
+366,702
New +$3.57M
JBL icon
1150
Jabil
JBL
$32.6B
$3.59M 0.01%
61,486
+41,838
+213% +$2.49M

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.05B of net new capital in Q3 2021, opening 1,118 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,118 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.